Janssen-Cilag International NV, a Johnson & Johnson company, today announced new frontline data featuring TECVAYLI®â–¼ (teclistamab) from two investigational studies in patients with newly diagnosed ...
Nijmegen, The Netherlands-based Alveron Pharma, a clinical-stage company, announced on Monday that it has secured €5M in a ...